Evolus (EOLS) Cash & Equivalents (2018 - 2026)

Evolus has reported Cash & Equivalents for 9 years, with the latest figure at $49.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 26.66% year-over-year to $49.8 million; the trailing twelve-month figure through Mar 2026 stood at $49.8 million (down 26.66% YoY), and the FY2025 full-year result was $53.8 million, down 38.1% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $49.8 million, down from $53.8 million in the prior quarter.
• The five-year high for Cash & Equivalents was $106.7 million in Q1 2022, with the low at $31.5 million in Q1 2023.
• Historically, Cash & Equivalents has averaged $66.2 million across 5 years, with a median of $62.8 million in 2023.
• Annual changes were most pronounced in 2022 — Cash & Equivalents jumped 381.13% — and 2023, when it plunged 70.5%.
• Evolus' Cash & Equivalents stood at $53.9 million in 2022, then advanced by 16.53% to $62.8 million in 2023, then surged by 38.37% to $87.0 million in 2024, then plunged by 38.1% to $53.8 million in 2025, then retreated by 7.49% to $49.8 million in 2026.
• The last three Cash & Equivalents figures came in at $49.8 million (Q1 2026), $53.8 million (Q4 2025), and $43.5 million (Q3 2025), per Business Quant data.